Phase1, Single Dose, Crossover Study to Determine Bioequivalence

Update Il y a 4 ans
Reference: NCT00786240

Woman and Man

  • | Country :
  • Singapore
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The objective of this study is to demonstrate bioequivalence of 4 mg tablet of formulation D and formulation E(1).


Inclusion criteria

  • Healthy

Links